WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-06-25·Latest →

UnitedHealth Group (UNH) Stock Analysis

OW

UNH Equity Research — OVERWEIGHT — June 2026

← TMO

Rating date

Jun 25, 2026

46 days ago

Desk view

OW

5D move

—

Awaiting market data

Peer rank

81p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · UNH

Here is the equity analysis note for UNH (UnitedHealth Group).

Desk rating

OW

Tactical OW · 12M OW

Horizon

Short to medium term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

OVERWEIGHT

Catalysts

  • UNH is in a well-defined long-term uptrend with a +38% gain over the trailing twelve months.
  • Near-term momentum is positive but decelerating — RSI is bullish (66.6) but MACD has narrowed, suggesting the pace of gains may be slowing.
  • Price is testing resistance near $410–$413; a clean break above this zone with volume would open the path toward the next psychological level (~$425–$430).

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

UNH Research Note

Full desk note for Jun 25, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

27 min read

WebserviceX · Agentic Research Desk

UNH Equity Research Note

Published Jun 25, 2026 · Desk view OVERWEIGHT · Generated 2026-06-26T08:30:23Z · Maintained by Walter Vijayakumar · Methodology · Track record

UNH Stock Rating Summary

UNH bias

OVERWEIGHT

Horizon

Short to medium term

UNH key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

UNH catalyst watch

UNH is in a well-defined long-term uptrend with a +38% gain over the trailing twelve months.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

—Awaiting market dataPeer 81p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-06-26T08:37:27.069392+00:00.

5D move

—

2026-06-25 → awaiting

Outcome

Awaiting market data

5D trend

+4.00%

Vol (20D ann.)

+24.48%

vs SPY: +4.65%

Close 415.53 → — (USD, vendor closes)

Batch scorecard · 2026-06-25 · UNH

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace 576d1af2…

No QC issues recorded.